By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

A significant issue is under enrollment of women in randomized trials, meaning the percentage of women enrolled isn’t in line ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

A newly uncovered U.S. military report reveals that over 400 Japanese were mobilized to run the Class-B and C Yokohama war ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...